Global Veterinary Vaccine Market is projected to grow at a CAGR of 6% between 2025 and 2034

According to the report, the global Veterinary Vaccine market size was valued at approximately USD 10.23 billion in 2024 and is projected to reach around USD 18.33 billion by the end of 2034, expanding at a CAGR of approximately 6% from 2025 to 2034. The report analyses the global Veterinary Vaccine market's drivers, restraints/challenges, and their effects on demand during the projection period. In addition, the report explores emerging opportunities in the Veterinary Vaccine industry

Browse the full “Veterinary Vaccine Market By Product (Livestock Vaccines, Companion Vaccines, And Others) By Technology Types (Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines, Toxoid Vaccines, And Others): Global Industry Perspective, Comprehensive Analysis And Forecast, 2025 – 2034.” Report at https://www.zionmarketresearch.com/report/veterinary-vaccine-market

Global Veterinary Vaccine Market: Overview

Veterinary vaccines are used mainly for livestock, as they suffer from various diseases, such as bluetongue virus, foot-and-mouth disease (FMD), and rabies. The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife.

Global Veterinary Vaccine Market: Growth Factors

The veterinary vaccine market is expected to grow rapidly due to driving factors such as an increase in the companion animal population, rising incidence of zoonotic diseases, initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products.

The outbreak of COVID-19 resulted in market players facing various challenges owing to the supply chain disruptions due to the stringent lockdown measures during the initial stages of the pandemic. However, the market will grow in the near future mainly due to companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. Technological advancement and growing awareness of animal health will also contribute towards the growth of the veterinary vaccine market.

Segmentation

The veterinary vaccine market is divided on the basis of product, technology types, and region. Based on the product, the veterinary market is bifurcated into livestock vaccine, companion vaccine, and others. On the basis of technology types, the veterinary vaccine is divided into attenuated vaccines, recombinant vaccines, inactivated vaccines, toxoid vaccines, and others.

Regional Analysis

The Asia Pacific is expected to grow at a rapid pace in the veterinary vaccines market due to factors such as the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand. Driving factors such as the anticipated rise in the livestock population, government initiatives, and high R&D expenditure are expected to boost the market growth in the region.

Europe is one of the most lucrative markets for veterinary vaccines due to rising production of veterinary products, improved animal husbandry practices, and a higher pet population, propelling the growth of the market in the region.

Veterinary Vaccine Market: Report Scope

Veterinary Vaccine Market: Competitive Analysis

The global veterinary vaccine market is led by players like:

• Boehringer Ingelheim Animal Health
• Zoetis
• Elanco Animal Health
• Merck Animal Health
• IDEXX Laboratories
• Ceva Santé Animale
• MSD Animal Health
• Virbac
• Vetoquinol
• Heska Corporation
• Zomedica Pharmaceuticals Corp.
• HIPRA
• Biogenesis Bago
• Zoetis India Ltd.
• Biogénesis Bagó.

The companies are forming various strategies to remain competitive in the market. Some of the strategies include product launches, agreements, and partnerships.

By Product 

• Livestock Vaccines
• Companion Vaccines
• Others

By Technology Types 

• Attenuated Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Others

By Regional 

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is updated constantly in order to provide our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com